The Autoimmune Disease Diagnostics Market is being driven by Advancements in laboratory automation platforms
The Autoimmune Disease Diagnostics Market is expected to grow at a CAGR of 9.59% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2988.16 million. In the realm of autoimmune diseases, companion diagnostics play a pivotal role by identifying individuals or groups who are most likely to benefit from specific therapeutic agents. The application of advanced companion diagnostic tests in this domain involves the integration of a diagnostic examination and ongoing monitoring of disease progression in patients undergoing treatment. These tests offer valuable insights into the therapeutic regimen's efficacy by mitigating the intensity of autoimmune diseases in select populations. The increasing emphasis on companion diagnostics will significantly contribute to the expansion of the global autoimmune disease diagnostics market throughout the forecast period.
Get more information on Autoimmune Disease Diagnostics Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Type (Localized autoimmune disease diagnostics, Systemic autoimmune disease diagnostics) Product (Assay kits, Analyzer) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Autoimmune Disease Diagnostics Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Autoimmune Disease Diagnostics Market involves various diagnostic tests for autoimmune disorders, including routine laboratory exams focusing on inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate, and complete blood count. Conditions like Rheumatoid Arthritis, Thyroiditis, Scleroderma, Systemic Autoimmune Disease, and Localized Autoimmune Disease are diagnosed using Antinuclear Antibody Tests and Autoantibody Tests. Multiple Sclerosis, an immune system disorder affecting the central nervous system, is diagnosed through multiple diagnostic tests like urinalysis and specific markers. The immune system, which normally protects the body, mistakenly attacks tissues and organs, resulting in the production of autoantibodies. Laboratory automation plays a crucial role in enhancing the accuracy and efficiency of these diagnostic tests. The Multiple Sclerosis Trust emphasizes the importance of early and accurate diagnosis for effective treatment.
The autoimmune disease diagnostics market is a significant segment of the global life science tools and services market. This market encompasses hospitals and diagnostic laboratories offering tests for systemic and localized autoimmune diseases. Key diagnostic tools include inflammatory markers, antinuclear antibody tests, and autoantibody tests. Technavio, a leading market research firm, includes this market within the larger global life sciences tools and services market. This market comprises manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, generating combined revenues that determine the market size. The global life sciences tools and services market caters to research and development (R&D) activities in various product categories, including capital equipment, instruments, accessories, and consumables, as well as life sciences-related services such as contract research, contract manufacturing, and contract sales.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
